These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies of decitabine with allogeneic progenitor cell transplantation. Giralt S, Davis M, O'Brien S, van Besien K, Champlin R, de Vos D, Kantarjian H. Leukemia; 1997 Mar; 11 Suppl 1():S32-4. PubMed ID: 9130690 [Abstract] [Full Text] [Related]
7. Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group. Schroeder T, Rautenberg C, Krüger W, Platzbecker U, Bug G, Steinmann J, Klein S, Hopfer O, Nachtkamp K, Kondakci M, Geyh S, Haas R, Germing U, Bornhäuser M, Kobbe G. Ann Hematol; 2018 Feb; 97(2):335-342. PubMed ID: 29151133 [Abstract] [Full Text] [Related]
8. Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias. de Lima M, Ravandi F, Shahjahan M, Andersson B, Couriel D, Donato M, Khouri I, Gajewski J, van Besien K, Champlin R, Giralt S, Kantarjian H. Cancer; 2003 Mar 01; 97(5):1242-7. PubMed ID: 12599231 [Abstract] [Full Text] [Related]
9. [Effect of decitabine on immune regulation in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation]. Wang J, Zhou J, Zheng HF, Fu ZZ. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct 01; 22(5):1448-52. PubMed ID: 25338605 [Abstract] [Full Text] [Related]
10. Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Cui JK, Xiao Y, You Y, Shi W, Li Q, Luo Y, Jiang L, Zhong ZD. J Huazhong Univ Sci Technolog Med Sci; 2017 Oct 01; 37(5):693-698. PubMed ID: 29058281 [Abstract] [Full Text] [Related]
11. Decitabine treatment for acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation. Liu XL, Zhao X, Wang C, Gao SJ, Tan YH. J Biol Regul Homeost Agents; 2017 Oct 01; 31(1):171-175. PubMed ID: 28337888 [Abstract] [Full Text] [Related]
12. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia. Mittal P, Saliba RM, Giralt SA, Shahjahan M, Cohen AI, Karandish S, Onida F, Beran M, Champlin RE, de Lima M. Bone Marrow Transplant; 2004 May 01; 33(10):1005-9. PubMed ID: 15048141 [Abstract] [Full Text] [Related]
13. Acute graft-versus-host disease in a nonhematopoietic stem cell transplantation candidate treated with decitabine followed by granulocyte colony-stimulating factor-primed peripheral blood stem cells infusion: a special entity of the disease? Yuan L, Sun L, Yang L, Jing Y. Transfusion; 2014 Jan 01; 54(1):190-3. PubMed ID: 23621702 [Abstract] [Full Text] [Related]
14. Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia. Craddock C, Labopin M, Robin M, Finke J, Chevallier P, Yakoub-Agha I, Bourhis JH, Sengelov H, Blaise D, Luft T, Hallek M, Kröger N, Nagler A, Mohty M. Haematologica; 2016 Jul 01; 101(7):879-83. PubMed ID: 27081178 [Abstract] [Full Text] [Related]
15. Decitabine prior to salvaged unrelated cord blood transplantation for refractory or relapsed childhood acute leukemia. Zhou H, Zheng C, Zhu X, Tang B, Tong J, Zhang X, Zhang L, Liu H, Sun Z. Pediatr Transplant; 2016 Dec 01; 20(8):1117-1124. PubMed ID: 27620713 [Abstract] [Full Text] [Related]
16. Decitabine as a conditioning regimen in haploidentical stem cell transplantation for refractory acute myeloid leukaemia. Zhang C, Chen XH, Liu J, Gao L, Liu Y, Gao L, Kong PY, Zhang X. J Clin Pharm Ther; 2015 Jun 01; 40(3):336-8. PubMed ID: 25825260 [Abstract] [Full Text] [Related]
17. Effect of Decitabine Combined with Unrelated Cord Blood Transplantation in an Adult Patient with -7/EVI1+ Acute Myeloid Leukemia: a Case Report and Literature Review. Jiang YZ, Su GP, Dai Y, He HS, Huang LQ, Sun ZM, Huang DP. Ann Clin Lab Sci; 2015 Jun 01; 45(5):598-601. PubMed ID: 26586716 [Abstract] [Full Text] [Related]
18. [The safety of decitabine as bridging pretreatment regimen before hematopoietic stem cell transplantation in pediatric hematological malignancies]. Fan LY, Hu SY, Xiao PF, Lu J, Li J, Yao YH, Ling J, Kong LJ, Liu H, Bian XN. Zhonghua Nei Ke Za Zhi; 2018 Sep 01; 57(9):679-682. PubMed ID: 30180454 [Abstract] [Full Text] [Related]
20. Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG). Becker H, Suciu S, Rüter BH, Platzbecker U, Giagounidis A, Selleslag D, Labar B, Germing U, Salih HR, Muus P, Pflüger KH, Hagemeijer A, Schaefer HE, Fiaccadori V, Baron F, Ganser A, Aul C, de Witte T, Wijermans PW, Lübbert M. Ann Hematol; 2015 Dec 01; 94(12):2003-13. PubMed ID: 26400023 [Abstract] [Full Text] [Related] Page: [Next] [New Search]